SMAD3 and cancer: In an in vitro experiment, inhibition of SMAD3 C-terminal phosphorylation reversed ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines, E4BP4-mediated NK cell development, and tumor metastasis (57, 60, 61).